These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6660381)

  • 81. Comments on "Placental vascular tree characterization based on ex-vivo MRI with a potential application for placental insufficiency assessment".
    Bertholdt C; Chen B; Dap M; Morel O; Beaumont M
    Placenta; 2020 Nov; 101():251. PubMed ID: 33092722
    [No Abstract]   [Full Text] [Related]  

  • 82. [The surveillance of pregnancies with suspected placental dysfunction. II. Antepartum fetal heart rate: the significance of baseline levels and accellerations (author's transl)].
    Schmid J
    Z Geburtshilfe Perinatol; 1975 Dec; 179(6):425-9. PubMed ID: 1241202
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Fetal challenge tests and non-stress tests. An analysis and comparison of the possibilities of predicting perinatal problems].
    Neldam S; Hansen T; Jessen P
    Ugeskr Laeger; 1981 Dec; 143(51):3465-9. PubMed ID: 7336506
    [No Abstract]   [Full Text] [Related]  

  • 84. Placental morphology: from molecule to mother -- a dedication to Peter Kaufmann -- a review.
    Huppertz B; Burton G; Cross JC; Kingdom JC
    Placenta; 2006 Apr; 27 Suppl A():S3-8. PubMed ID: 16542720
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [The placenta in the fetal growth retardation syndrome (SFD)].
    De Virgiliis G; Bianco V; Cima P; Crippa A; Remotti G
    Ann Ostet Ginecol Med Perinat; 1978; 99(2):75-94. PubMed ID: 655548
    [No Abstract]   [Full Text] [Related]  

  • 86. [Personal experience in the treatment of placental insufficiency with cytidine diphosphocholine].
    Zardini E; Cattani P; Maffetti G; Zanoio L
    Minerva Ginecol; 1980 Nov; 32(11):1057-64. PubMed ID: 7194455
    [No Abstract]   [Full Text] [Related]  

  • 87. [Characteristics of the development during the 1st year of life of children born to mothers with threatened premature labor of the endocrine etiology].
    Kuznetsova VA; Volkova TG
    Pediatriia; 1989; (6):8-11. PubMed ID: 2762061
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Thermostable alkaline phosphatase, oxytocinase, uterine estriol and placental function].
    Díaz Infante JS; Fonseca Yerena ME; Murrieta Necoechea S; Karchmer S
    Ginecol Obstet Mex; 1971 Nov; 30(181):567-75. PubMed ID: 5131139
    [No Abstract]   [Full Text] [Related]  

  • 89. Perfusion of the intervillous space of the human placenta measured with 99mtechnetium labelled human serum albumin.
    Andersen KV; Andersen SV; Munck O; Larsen JF; Nielsen SL; Kjeldsen H
    Clin Physiol; 1982 Apr; 2(2):89-95. PubMed ID: 6211329
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Correlation between placental lactogen concentration and the serum protein spectrum in women with chronic placental insufficiency].
    Goriachev VV
    Vopr Okhr Materin Det; 1978 Jul; 23(7):77-80. PubMed ID: 685214
    [No Abstract]   [Full Text] [Related]  

  • 91. [Diagnostic possibilities of serum immunoreactive estriol (E3) in fetal hypotrophy of different etiology].
    Ananiev V
    Akush Ginekol (Sofiia); 1984; 23(3):220-5. PubMed ID: 6476277
    [No Abstract]   [Full Text] [Related]  

  • 92. [Clinical significance of uteroplacental circulation and its determination in the total complex of monitoring risk pregnancy].
    Voigt R
    Z Arztl Fortbild (Jena); 1983; 77(7):301-3. PubMed ID: 6858233
    [No Abstract]   [Full Text] [Related]  

  • 93. [Placental maturity at term and functional placental performance: CTG changes in relation to histologic detection of placental maturation reserves].
    Beck T; Weber G; Weikel W
    Geburtshilfe Frauenheilkd; 1991 Sep; 51(9):714-21. PubMed ID: 1743471
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Pathology of the placenta. XIII. Pathological anatomy of the placenta and placental insufficiency].
    Emmrich P
    Zentralbl Pathol; 1993 Mar; 139(1):1-9. PubMed ID: 8499415
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [The pathogenesis, early diagnosis, and pharmacocorrection of fetal condition disturbances in high risk pregnancy].
    Strizhakov AN; Ignatko IV; Rybin MV; Dubalazov VD
    Vestn Ross Akad Med Nauk; 2006; (9-10):104-14. PubMed ID: 17111934
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Role and results of placental scintigraphy in modern obstetrics (author's transl)].
    Renziehausen K; Mende HM; Basche S; Endert G
    Zentralbl Gynakol; 1980; 102(16):889-96. PubMed ID: 7456886
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The DHEA-S loading test in the evaluation of fetoplacental function.
    Gummerus M
    Acta Obstet Gynecol Scand; 1974; 53(4):319-22. PubMed ID: 4280228
    [No Abstract]   [Full Text] [Related]  

  • 98. [State of the fetus and newborn infant depending on functional placental insufficiency].
    Boryma TV; Nitsovych RM; Hirman VI; Vaniiev RA; Zbykovs'ka LI
    Pediatr Akus Ginekol; 1978; (6):49-51. PubMed ID: 733386
    [No Abstract]   [Full Text] [Related]  

  • 99. Does the presence of a uterine scar influence the site of placental implantation?
    Carbillon L
    Ultrasound Obstet Gynecol; 2013 Jul; 42(1):121. PubMed ID: 23798550
    [No Abstract]   [Full Text] [Related]  

  • 100. T2*-weighted placental MRI: basic research tool or emerging clinical test for placental dysfunction?
    Sørensen A; Hutter J; Seed M; Grant PE; Gowland P
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):293-302. PubMed ID: 31452271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.